Correlation Between Ocean Biomedical and Royalty Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ocean Biomedical and Royalty Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ocean Biomedical and Royalty Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ocean Biomedical and Royalty Pharma Plc, you can compare the effects of market volatilities on Ocean Biomedical and Royalty Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ocean Biomedical with a short position of Royalty Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ocean Biomedical and Royalty Pharma.

Diversification Opportunities for Ocean Biomedical and Royalty Pharma

0.84
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Ocean and Royalty is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Ocean Biomedical and Royalty Pharma Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Royalty Pharma Plc and Ocean Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ocean Biomedical are associated (or correlated) with Royalty Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Royalty Pharma Plc has no effect on the direction of Ocean Biomedical i.e., Ocean Biomedical and Royalty Pharma go up and down completely randomly.

Pair Corralation between Ocean Biomedical and Royalty Pharma

Given the investment horizon of 90 days Ocean Biomedical is expected to under-perform the Royalty Pharma. In addition to that, Ocean Biomedical is 3.41 times more volatile than Royalty Pharma Plc. It trades about -0.24 of its total potential returns per unit of risk. Royalty Pharma Plc is currently generating about -0.05 per unit of volatility. If you would invest  2,697  in Royalty Pharma Plc on August 31, 2024 and sell it today you would lose (37.00) from holding Royalty Pharma Plc or give up 1.37% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Ocean Biomedical  vs.  Royalty Pharma Plc

 Performance 
       Timeline  
Ocean Biomedical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ocean Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Royalty Pharma Plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Royalty Pharma Plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Ocean Biomedical and Royalty Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ocean Biomedical and Royalty Pharma

The main advantage of trading using opposite Ocean Biomedical and Royalty Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ocean Biomedical position performs unexpectedly, Royalty Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Royalty Pharma will offset losses from the drop in Royalty Pharma's long position.
The idea behind Ocean Biomedical and Royalty Pharma Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals